Meridian Bioscience (VIVO) Reports In-Line Q4 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Craig-Hallum Downgrades Meridian Biosciences (VIVO) to Hold
November 14, 2016 12:53 PM ESTCraig-Hallum downgraded Meridian Biosciences (NASDAQ: VIVO) from Buy to Hold.
For an analyst ratings summary and ratings history on Meridian Biosciences click here. For more ratings news on Meridian Biosciences click here.
Shares of Meridian Biosciences closed at $17.40 yesterday.
... MoreMeridian Bioscience (VIVO) Declares $0.20 Quarterly Dividend; 4.7% Yield
November 10, 2016 7:48 AM ESTMeridian Bioscience (NASDAQ: VIVO) declared a quarterly dividend of $0.20 per share, or $0.8 annualized.
The dividend will be payable on December 1, 2016, to stockholders of record on November 21, 2016, with an ex-dividend date of November 17, 2016.
The annual yield on the dividend is 4.7 percent.
For... More
